High levels of myogenic tone antagonize the dilator response to flow of small rabbit cerebral arteries.
OBJECTIVE
Pressure and shear stress exerted by flowing blood are two mechanical forces that play a major role in the regulation of vascular tone. We sought to evaluate the interaction between pressure and flow in isolated rabbit cerebral arteries.


METHODS
Responses to intraluminal flow of isolated pressurized rabbit posterior cerebral arteries were investigated at low, medium, and high levels of myogenic tone by setting the luminal pressure at 40, 60, and 80 mm Hg, respectively.


RESULTS
At both low and medium levels of myogenic tone, flow induced dilation. The response was significantly larger at 40 than at 60 mm Hg. At the high level of myogenic tone, the response to flow consisted of a combination of an initial transient dilation followed by sustained constriction. Flow-induced dilation but not flow-induced constriction response was endothelium dependent. Removal of the endothelium inhibited the dilator response by approximately 80%. Flow-induced dilation was inhibited (approximately 40%) by N omega-nitro-L-arginine (100 mumol/L) but not by indomethacin (10 mumol/L). Endothelium removal not only decreased the amplitude of flow-induced dilation but also promoted the appearance of flow-induced constriction at low and medium levels of myogenic tone.


CONCLUSIONS
The intraluminal pressure and in consequence the level of myogenic tone at which flow is applied determine the nature of the response of the smooth muscle cells of the blood vessel wall.
Thorin-Trescases
N
N
Totman Laboratory for Cerebrovascular Research, Department of Pharmacology, College of Medicine, University of Vermont, Burlington, USA.
Bevan
J A
JA
D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D002536:Cerebral Arteries / Q000502:physiology*; D002560:Cerebrovascular Circulation / Q000502:physiology*; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D009129:Muscle Tonus / Q000502:physiology*; D018482:Muscle, Skeletal / Q000098:blood supply / Q000502:physiology*; D019335:Nitroarginine / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology; D011817:Rabbits; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology*
D016861:Cyclooxygenase Inhibitors; D004791:Enzyme Inhibitors; D014662:Vasoconstrictor Agents; D019335:Nitroarginine; D011189:Potassium Chloride; D007213:Indomethacin